These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38044587)

  • 1. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
    Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
    Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum free light chain analysis: persisting limitations with new kids on the block.
    Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
    Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
    Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
    Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
    Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
    Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
    Lutteri L; Aldenhoff MC; Cavalier E
    Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2 Free Light Chain Assays: Performance of the Free Light Chain Ratio as a Risk Factor for MGUS Progression.
    Wang Q; Andress BD; Pazdernik VMK; Larson DR; Coker JD; Dasari S; Rajkumar V; Dispenzieri A; Murray DL; Willrich MAV
    Clin Chem; 2024 Oct; 70(10):1268-1278. PubMed ID: 39206639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
    Augustijn D; Jacobs JFM; Russcher H
    Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment.
    Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K
    Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
    Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
    Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
    Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
    Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2 Serum Free Light Chain Assays with Creatinine Normal and Abnormal Populations Demonstrates the Need for Standardization.
    Griffiths M; Cheng PL; Wang XY; Schneider R; Kulasingam V
    J Appl Lab Med; 2024 Sep; 9(5):978-988. PubMed ID: 38973026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
    Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
    Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Long-Term Storage on Serum Free Light Chain Stability.
    Hörber S; Klein R; Peter A
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
    Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
    Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Freelite and N-Latex serum free light chain assays: a critical review.
    Daves M; Piccin A; Roccaforte V; Lippi G
    Biochem Med (Zagreb); 2021 Oct; 31(3):030701. PubMed ID: 34393594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
    Morales-García LJ; Pacheco-Delgado MS
    Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma.
    Caillon H; Avet-Loiseau H; Attal M; Moreau P; Decaux O; Dejoie T
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e228-e237. PubMed ID: 30799237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.